Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis Fatigue
Change in Modified Fatigue Impact Scale scores did not differ between the groups
ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated
Second study shows that only 14 percent of patients correctly identified symptoms requiring epinephrine
CDC Says Some People May Need Extra Dose of COVID Vaccine
By Robin Foster HealthDay Reporter
FRIDAY, Oct. 25, 2024 (HealthDay News) -- Some Americans should get more than one shot of the updated COVID vaccines...
Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis
Findings seen through 76 weeks of treatment for adolescents taking 15- or 30-mg doses for moderate-to-severe atopic dermatitis
ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema
Reduction of 75 and 77 percent seen in estimated mean monthly attack rate with 25-mg, 50-mg NTLA-2002 versus placebo
CDC Lowers Age for First Pneumococcal Vaccine to 50
By Ernie Mundell HealthDay Reporter
THURSDAY, Oct. 24, 2024 (HealthDay News) -- The recommended first age at which Americans should get the pneumococcal vaccine has...
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
Vyloy is the first and only CLDN18.2-targeted therapy approved in the United States
AAO: One Year of Valacyclovir Beneficial for Herpes Zoster Ophthalmicus
Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir
Abortions Have Increased, Even in States With Bans, Report Finds
By Robin Foster HealthDay Reporter
WEDNESDAY, Oct. 23, 2024 (HealthDay News) -- A new report shows the number of women getting abortions in the United...
AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine
Corneal toxicity not uncommon with MIRV treatment for primary gynecologic malignancies, usually resolves